|
|
Volumn 12, Issue 3, 2015, Pages 124-
|
|
Gastric cancer: Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METFORMIN;
ANTIDIABETIC AGENT;
ANTINEOPLASTIC AGENT;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RECURRENCE;
CLINICAL EFFECTIVENESS;
DRUG RESPONSE;
FOLLOW UP;
GASTRECTOMY;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RECURRENCE FREE SURVIVAL;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SOUTH KOREA;
STOMACH CANCER;
SURVIVAL RATE;
ADJUVANT CHEMOTHERAPY;
COMPLICATION;
DIABETES MELLITUS, TYPE 2;
RECURRENT DISEASE;
STOMACH NEOPLASMS;
SURVIVAL;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
RECURRENCE;
RETROSPECTIVE STUDIES;
STOMACH NEOPLASMS;
SURVIVAL ANALYSIS;
|
|
EID: 84924279764
PISSN: 17595045
EISSN: 17595053
Source Type: Journal
DOI: 10.1038/nrgastro.2015.9 Document Type: Note |
|
Times cited : (33)
|
|
References (1)
|
